Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Journal of Reproduction and Infertility. 2012; 13 (1): 3-11
in English | IMEMR | ID: emr-163113

ABSTRACT

The number of couples seeking consultation for infertility problems has steadily increased over the past decade, affecting 10%-15% of the sexually active population. Abnormal semen production, a male factor infertility [MFI], is thought to be the cause of up to 50% of all infertilities in developed countries. There are potentially many different causes of male infertility, including hormonal, anatomical, and secondary to exposure to exogenous substances. In many cases of MFI, a definitive cause for abnormalities is never identified. Recently, the research community has given greater attention to identifying causes of MFI ranging from genetic Y chromosome microdeletions to mechanisms of environmental damage on sperm production. Still evolving, is a clear understanding of how many pharmaceutical medications may cause MFI, which is often treatable and reversible. In this review we will out-line the data regarding various pharmaceutical medications that have been investigated as possible causes of MFI


Subject(s)
Humans , Male , Infertility, Male/etiology , Calcium Channel Blockers/adverse effects , Antidepressive Agents/adverse effects , Adrenergic alpha-Antagonists/adverse effects , Anticonvulsants/adverse effects , Anti-Retroviral Agents/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL